Mads Christiansen, a Danish GP and CEO of New Deal Invest, and Sekander Amini, a UK pharmacy owner and Hims investor, share insights on the European healthcare landscape. They tackle how Hims’ U.S. strategies need to adapt to Europe’s free healthcare systems and discuss the benefits of telehealth amidst NHS challenges. They explore the potential of personalized medicine, AI innovations, and the complexities of pharmaceutical advertising across different regulations, revealing a future of streamlined, tech-driven healthcare solutions.
